The Australian Medical Oncologist Workforce Survey: The profile and challenges of medical oncology
Zarnie Lwin(The University of Queensland), Rosemary Harrup(University of Tasmania), Christos S. Karapetis(Clínica Alemana), Alex Broom(The University of Sydney), Kay Francis(Medical Oncology Group of Australia), Deme Karikios(The University of Sydney), David Sibbritt(University of Technology Sydney)
Cited by 17
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Cetuximab for the Treatment of Colorectal Cancer
|New England Journal of Medicine|2007|1.8k
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
|The Lancet Oncology|2019|537